Bank of New York Mellon’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Buy |
237,683
+25,018
| +12% | +$1.33M | ﹤0.01% | 1759 |
|
|
2025
Q1 | $8.61M | Buy |
212,665
+12,235
| +6% | +$495K | ﹤0.01% | 1919 |
|
|
2024
Q4 | $5.58M | Sell |
200,430
-6,414
| -3% | -$178K | ﹤0.01% | 2224 |
|
|
2024
Q3 | $5.93M | Sell |
206,844
-44,390
| -18% | -$1.27M | ﹤0.01% | 2209 |
|
|
2024
Q2 | $5.89M | Buy |
251,234
+61,988
| +33% | +$1.45M | ﹤0.01% | 2249 |
|
|
2024
Q1 | $4.78M | Buy |
189,246
+11,451
| +6% | +$289K | ﹤0.01% | 2345 |
|
|
2023
Q4 | $4.15M | Sell |
177,795
-322,450
| -64% | -$7.53M | ﹤0.01% | 2462 |
|
|
2023
Q3 | $25.3M | Buy |
500,245
+346,317
| +225% | +$17.5M | 0.01% | 1420 |
|
|
2023
Q2 | $7.19M | Buy |
153,928
+31,336
| +26% | +$1.46M | ﹤0.01% | 2121 |
|
|
2023
Q1 | $4.69M | Sell |
122,592
-17,890
| -13% | -$684K | ﹤0.01% | 2337 |
|
|
2022
Q4 | $7.7M | Buy |
140,482
+27,592
| +24% | +$1.51M | ﹤0.01% | 2083 |
|
|
2022
Q3 | $3.84M | Buy |
112,890
+26,813
| +31% | +$913K | ﹤0.01% | 2440 |
|
|
2022
Q2 | $814K | Buy |
86,077
+4,495
| +6% | +$42.5K | ﹤0.01% | 3311 |
|
|
2022
Q1 | $1.16M | Buy |
81,582
+2,793
| +4% | +$39.6K | ﹤0.01% | 3218 |
|
|
2021
Q4 | $1.67M | Buy |
78,789
+1,675
| +2% | +$35.4K | ﹤0.01% | 3100 |
|
|
2021
Q3 | $1.72M | Buy |
77,114
+7,393
| +11% | +$165K | ﹤0.01% | 3072 |
|
|
2021
Q2 | $1.73M | Buy |
69,721
+15,073
| +28% | +$374K | ﹤0.01% | 3086 |
|
|
2021
Q1 | $1.59M | Sell |
54,648
-5,584
| -9% | -$162K | ﹤0.01% | 3053 |
|
|
2020
Q4 | $1.55M | Sell |
60,232
-10,696
| -15% | -$276K | ﹤0.01% | 2986 |
|
|
2020
Q3 | $2.18M | Buy |
70,928
+30,240
| +74% | +$931K | ﹤0.01% | 2617 |
|
|
2020
Q2 | $1.01M | Buy |
40,688
+13,232
| +48% | +$330K | ﹤0.01% | 3109 |
|
|
2020
Q1 | $582K | Buy |
27,456
+8,488
| +45% | +$180K | ﹤0.01% | 3279 |
|
|
2019
Q4 | $421K | Buy |
18,968
+8,001
| +73% | +$178K | ﹤0.01% | 3671 |
|
|
2019
Q3 | $250K | Buy |
+10,967
| New | +$250K | ﹤0.01% | 3836 |
|